An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Treatment Gaining Traction Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are urged to contact these accounts privately for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Worries
However, physicians and chemists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals administering products of unknown origin.
Some professionals said the popularity for the experimental drug could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.
Some content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Platform Response and Material Removal
Based on TikTok, the platform has taken down problematic material and prohibited associated hashtags and search suggestions. The company said it was dedicated to keeping the service secure and investing in strengthening enforcement strategies.
Online Marketplace Activities
Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of users, filled with photos of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within minutes of joining one community, a vendor shared contact information, where the majority of purchases occur. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.
Item Details and Costs
Inside these communities, messages show dark colored parcels with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with purified liquid, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for Telegram said it regularly monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering substances they can’t verify. Even if the research behind retatrutide is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her staff has already encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject users to potentially serious medical dangers”.
